These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28840494)

  • 1. Ultrapure dialysis water obtained with additional ultrafilter may reduce inflammation in patients on hemodialysis.
    Di Iorio B; Di Micco L; Bruzzese D; Nardone L; Russo L; Formisano P; D'Esposito V; Russo D
    J Nephrol; 2017 Dec; 30(6):795-801. PubMed ID: 28840494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
    Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
    J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study.
    Panichi V; Scatena A; Rosati A; Giusti R; Ferro G; Malagnino E; Capitanini A; Piluso A; Conti P; Bernabini G; Migliori M; Caiani D; Tetta C; Casani A; Betti G; Pizzarelli F
    Nephrol Dial Transplant; 2015 Apr; 30(4):682-9. PubMed ID: 25385719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy to reduce inflammation and anemia treatment's related costs in dialysis patients.
    Di Iorio BR; Di Micco L; Russo L; Nardone L; De Simone E; Sirico ML; Di Natale G; Russo D
    G Ital Nefrol; 2018 Feb; 35(1):. PubMed ID: 29390245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin-free dialysate improves response to erythropoietin in hemodialysis patients.
    Matsuhashi N; Yoshioka T
    Nephron; 2002; 92(3):601-4. PubMed ID: 12372943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteria and endotoxin removal from bicarbonate dialysis fluids for use in conventional, high-efficiency, and high-flux hemodialysis.
    Oliver JC; Bland LA; Oettinger CW; Arduino MJ; Garrard M; Pegues DA; McAllister S; Moone T; Aguero S; Favero MS
    Artif Organs; 1992 Apr; 16(2):141-5. PubMed ID: 10078235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis.
    Arizono K; Nomura K; Motoyama T; Matsushita Y; Matsuoka K; Miyazu R; Takeshita H; Fukui H
    Blood Purif; 2004; 22 Suppl 2():26-9. PubMed ID: 15655319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional versus ultrapure dialysate for lowering serum lipoprotein(a) levels in patients on long-term hemodialysis: a randomized trial.
    Tao J; Sun Y; Li X; Li H; Liu S; Wen Y; Duan L; Li Y; Li X
    Int J Artif Organs; 2010 May; 33(5):290-6. PubMed ID: 20593350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the quality of water used for dialysis on the efficacy of hemodialysis: a single-center experience from Morocco.
    Akhmouch I; Asserraji M; Bahadi A; Bouaiti E; Alayoude M; Aatif T; Hamzi MA; Kawtar H; Allam M; Oualim Z
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):576-80. PubMed ID: 21566327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study.
    Schneider A; Drechsler C; Krane V; Krieter DH; Scharnagl H; Schneider MP; Wanner C;
    Clin J Am Soc Nephrol; 2012 Jan; 7(1):52-9. PubMed ID: 22096040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous C.E.R.A. for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study.
    Warady BA; Meyer Reigner S; Tirodkar C; Drozdz D
    Am J Kidney Dis; 2023 Jun; 81(6):684-694.e1. PubMed ID: 36587890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of using ultrapure dialysate for hemodialysis on the level of circulating bacterial fragment in renal failure patients.
    Kwan BC; Chow KM; Ma TK; Cheng PM; Leung CB; Li PK; Szeto CC
    Nephron Clin Pract; 2013; 123(3-4):246-53. PubMed ID: 24008429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized pilot study on the effects of two synthetic high-flux dialyzers on dialysis patient anemia.
    Viganò SM; Filippo SD; Milia VL; Pontoriero G; Locatelli F
    Int J Artif Organs; 2012 May; 35(5):346-51. PubMed ID: 22684617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of lipid A and Pseudomonas aeruginosa endotoxin from dialysis fluids by high-flux polysulfone ultrafilter (dialyzer).
    Rafiee-Tehrani M; Farrokhnia R; Falkenhagen D; Weber C
    PDA J Pharm Sci Technol; 1996; 50(5):306-10. PubMed ID: 8973116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.
    Hasegawa T; Nakai S; Masakane I; Watanabe Y; Iseki K; Tsubakihara Y; Akizawa T
    Am J Kidney Dis; 2015 Jun; 65(6):899-904. PubMed ID: 25641063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.
    Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A
    Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Water Treatment on Anemia in Hemodialysis Patients.
    Hassan MS; Hebah HA; Mourad TAH; El-Sharabasy RM
    Indian J Nephrol; 2023; 33(3):183-187. PubMed ID: 37448903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of ultrapure dialysis liquid in response to the treatment of renal anaemia with darbepoetin in patients receiving haemodialysis].
    Molina M; Navarro MJ; Palacios ME; de Gracia MC; García Hernández MA; Ríos Moreno F; Pérez Silva FM
    Nefrologia; 2007; 27(2):196-201. PubMed ID: 17564565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.